Life ScienceCompany
Bio-Techne M&A Summary
Bio-Techne has acquired 18 companies, including 6 in the last 5 years. A total of 3 acquisitions came from private equity firms.
Bio-Techne’s largest acquisition to date was in 2021, when it acquired Asuragen for $320M. Bio-Techne has acquired in 8 different US states, and 4 countries. The Company’s most targeted sectors include life science (62%) and medical products (17%).
Bio-Techne Business Overview
Where is Bio-Techne headquartered?
Bio-Techne is headquartered in Minneapolis, Minnesota.
What is Bio-Techne’s revenue?
Bio-Techne disclosed revenue of 1,137M USD for 2023 and 1,106M USD for 2022.
How many employees does Bio-Techne have?
Bio-Techne has 3,200 employees.
What sector is Bio-Techne in?
Bio-Techne is a life science company.
When was Bio-Techne founded?
Bio-Techne was founded in 1976.
M&A Summary
-
M&A Total Activity18
- M&A Buy Activity18
- Total Sectors Invested 6
- Total Countries Invested 4
- M&A Buy/Sell Connections 3
- M&A Advisors 2